乙型病毒性肝炎

yǐ xínɡ bìnɡ dú xìnɡ ɡān yán
  • viral hepatitis B
乙型病毒性肝炎乙型病毒性肝炎
  1. 乙型病毒性肝炎传播途径的探讨

    The discussion of the route of transmission of viral hepatitis B

  2. HLA-Ⅱ类和Ⅲ类基因与乙型病毒性肝炎相关性的研究

    Study on the Association between HLA Class ⅱ, ⅲ Genes and Viral Hepatitis B

  3. 乙型病毒性肝炎(hepatitisB,乙型肝炎)是危害我国人民健康最严重的疾病之一,我国携带HBsAg的总人数超过1亿人。

    Hepatitis B is one of most severe worldwide diseases . There are about 120 millions HBsAg carriers in China .

  4. HDV阳性乙型病毒性肝炎血清和肝内HBVdna状态的研究

    A Study of the Appearence of HBV DNA in the Serum and Liver of Patients with HDV / HBV Infection

  5. 39例慢性乙型病毒性肝炎血清HBV-DNA检测结果分析

    Determination of Serum HBV-DNA in 39 Cases of Hepatitis B & A Clinical Analysis

  6. 关于乙型病毒性肝炎HBeAg阳性者是否易转为慢性的探讨&附100例临床观察

    Are Patients with HBeAg Positive Liable to be Chronic ? & Observation in 100 Cases

  7. 重型乙型病毒性肝炎患者血清IL-1、IL-6、TNF-α水平与肝细胞坏死程度密切相关,检测血清中IL-1、IL-6、TNF-α对判断病情危重程度和预后有重要意义。

    Detect serum IL-1 , IL-6 and TNF - α is helpful for judging the degree hepatitis and its prognosis .

  8. 目的探讨ABO血型与乙型病毒性肝炎多重感染的关系。

    Objective To study the correlation of ABO blood type and multi-infection of hepatitis B virus .

  9. 原发性肝癌与乙型病毒性肝炎(viralhepatitistypeB,简称乙肝)关系密切,特别是转为慢性肝炎后肝脏的纤维化是原发性肝癌的发病基础。

    There is a close relationship between the primary hepatic cancer and the viral hepatitis type B. Especially the liver fibrosis is the foundation of PHC after it turn to chronic hepatitis .

  10. 背景:慢性乙型病毒性肝炎感染乙型肝炎病毒(HBV)后,机体体液及细胞免疫引起的以肝脏损伤为主的全身性疾病。

    Background : Chronic hepatitis B , hepatitis B virus ( HBV ) infection , liver damage caused by the humoral and cellular immune systemic disease .

  11. 乙型病毒性肝炎血清IL-1、IL-8和TNF-α检测及意义

    Detection of IL-1 , IL-8 and TNF - α in serum samples from patients with viral hepatitis B and its significance

  12. 慢性乙型病毒性肝炎的诊断及鉴别诊断&30例肝穿刺的光镜、电镜观察及HBsAg检测研究

    Diagnosis and Differential Diagnosis of Chronic Virus B Hepatitis : 30 Cases of Liver Biopsy studied with Light and Electron Microscopy and HBsAg Test

  13. 目的:探讨SARS病人与慢性乙型病毒性肝炎病人的焦虑水平差异,以及SARS病人焦虑水平的性别特点、年龄特点以及与文化程度的关系。

    Objective : to probe into the features in sex , age of anxiety level and its relations with education level in patients with SARS .

  14. HBeAg阴性慢性乙型病毒性肝炎合并肝脂肪变的预测指标和其对纤维化的诊断价值

    Predictors for clinical pathological characteristic in HBeAg negative chronic hepatitis B patients with steatosis and its diagnostic value for hepatic fibrosis

  15. 结论α2b干扰素联合苦参碱是治疗慢性乙型病毒性肝炎较有效的方法。

    Conclusion The combination of α - 2b interferon and matrine is an effective method in the treatment of chronic hepatitis B.

  16. 目的:探讨自身免疫性肝炎(AIH)与慢性乙型病毒性肝炎重叠综合征的临床及诊断。

    Objective To discuss the clinical and diagnosis of overlapped synthesis of AIH and .

  17. 应用夹心ELISA检测了56例乙型病毒性肝炎患者外周血单个核细胞(PBMCs)白细胞介素-6(IL-6)的诱生水平。

    Interleukin-6 ( IL-6 ) induced from peripheral mononuclear cells ( PBMCs ) of 56 patients with viral hepatitis B was detected by sandwich ELISA .

  18. 目的:探讨HBVx区基因用于乙型病毒性肝炎早期诊断价值和意义。

    Objective : To explore the significance and value of HBV X region genes in the early diagnosis of Hepatitis B.Methods : The partial gene sequence of HBV X region in pBR322-HBV was amplified by PCR .

  19. 目的:评价干扰素联合苦参素治疗慢性乙型病毒性肝炎(CHB)的疗效。

    OBJECTIVE : To evaluate the therapeutic effects of interferon combined with kushenin in the treatment of Chronic Hepatitis B ( CHB ) .

  20. 目的观察α2b干扰素联合苦参碱治疗慢性乙型病毒性肝炎的临床疗效及对乙肝病毒标志物的影响。

    Objective To observe the clinical effect of α - 2b interferon and matrine on treatment of chronic hepatitis B and the influence of HBV markers .

  21. 乙型病毒性肝炎患者血清IL-2、slL-2R、IL-13及PDGF测定的意义

    Clinical Significance of Determination of Changes of Serum IL-2 , sIL-2R , IL-13 and PDGF Levels in Patients with Viral Hepatitis B

  22. 研究背景:慢性乙型病毒性肝炎是由乙型肝炎病毒(HBV)感染人体及机体免疫功能低下所引起的以肝脏损伤为主的全身性疾病,是严重危害人类生命健康的传染病。

    Background : Chronic hepatitis B is systemic disease by hepatitis B virus ( HBV ) infection and damage caused by immune dysfunction , it is a serious infectious disease against humanity , life and health .

  23. 目的:观察健脾疏肝汤对慢性乙型病毒性肝炎患者病毒指标(HBV-M、HBV-DNA)的影响。

    Objective : To study the effect of Jianpi-Shugan Decoctum in treating the patients with chronic hepatitis B by observing HBV-M , HBV-DNA .

  24. 血清可溶性HLA-I及肝组织HLA-I表达水平与乙型病毒性肝炎的临床相关性研究

    The Relationship between Liver HLA-I 、 Soluble HLA-I and Inflammation Grade in Patients with Hepatitis B

  25. 目的了解本辖区食品和公共场所从业人员乙型病毒性肝炎(HBV)感染情况及其分布特点及HBsAg阳性与HBeAg和ALT(谷丙转氨酶)之间的相互关系。

    OBJECTIVES To know the infectious status and distribution speciality of hepatitis B virus in food and public places personnel in this district , and the correlation of positive HBsAg and HBeAg with ALT.

  26. 目的明确总胆汁酸(TBA)在判断慢性乙型病毒性肝炎患者肝脏炎症分级及纤维化分期中的价值。

    Objective To determine the role of total bile acid ( TBA ) in evaluating the degree of inflammation and fibrosis of liver in patients with chronic hepatitis B.

  27. 目的评价慢性乙型病毒性肝炎(CHB)患者血清转化生长因子β1(TGFβ1)测定的临床意义。

    Objective To evaluate the clinical significance of determining the serum transforming growth factor beta-1 ( TGF - β 1 ) in the patients with chronic viral hepatitis B ( CHB ) .

  28. 结论干扰素α-1b是目前治疗慢性乙型病毒性肝炎较为有效且安全的可选择的药物,尤其对女性、高ALT水平、HBV-DNA低拷贝数(≤106copies/ml)的慢性乙肝患者更为有效。

    Conclusion α - 1b interferon is one of the effective and safety medicines for treating CHB especially to females or those with higher ALT level or HBV-DNA ≤ 106 copies / ml.

  29. 目的观察重组基因干扰素α-1b治疗慢性乙型病毒性肝炎(CHB)的临床疗效、影响因素及其安全性。

    Objective To observe the clinic effect , impact factors and safety of recombinant human interferon α - 1b for treating chronic hepatitis B ( CHB ) cases .

  30. 方法用酶标法检测75例慢性乙型病毒性肝炎和40例乙肝后肝硬化患者血清中MMP9浓度。

    MethodsSerum MMP-9 was detected by ELISA in75 patients with CHB and40 patients with LC and20 healthy persons .